The Testosterone Debate in the U.S. Military: Why Pete Hegseth’s Call Rings Loudly

When Pete Hegseth took to his podcast last month to warn that “testosterone is the glue that holds the military together,” the reaction was predictably mixed. Some listeners cheered, seeing his words as a blunt reminder of the physical demands of combat. Others cringed, calling his phrasing a thinly veiled jab at the Department of Defense’s recent efforts to accommodate transgender service members.

Hegseth’s central thesis is simple, if not entirely novel: the armed forces have always prized rugged, biologically male soldiers, and any shift toward hormone‑based criteria for service risks eroding that foundation. He points to the Army’s 2023 policy allowing service‑connected gender‑affirming care as a case in point, suggesting that it opens the door to a slippery slope where readiness could be compromised.

But the reality on the ground is messier than a headline sound bite. The military already conducts rigorous medical screenings that include hormone panels—primarily to detect endocrine disorders that could impair performance, not to police masculinity. In many combat units, soldiers undergo blood work to ensure they’re fit for duty, whether they’re checking iron levels, glucose, or yes, testosterone.

What Hegseth seems to overlook is that low testosterone can be a symptom of stress, injury, or chronic illness—issues that any soldier, regardless of gender, might face after a grueling deployment. In fact, the Army’s own research has shown that endocrine imbalances, including low testosterone, can correlate with decreased endurance and slower recovery times.

Meanwhile, the conversation about transgender service members isn’t about swapping one set of hormones for another. It’s about allowing individuals to serve in alignment with their gender identity, which, for many, involves hormone therapy as a medically necessary treatment. The Department of Defense’s policy doesn’t mandate that all soldiers undergo such therapy; it simply removes a barrier that once forced qualified individuals out of uniform.

Critics, including Hegseth, argue that permitting hormone therapy could create “units of two‑speed” where some soldiers are allegedly less capable. Yet the data that the Pentagon has released so far tells a different story. In the first year after reinstating transgender service, there were no documented incidents of reduced combat effectiveness linked directly to hormone treatment. Moreover, retention rates among transgender soldiers have actually improved, suggesting that inclusivity may boost morale—a factor that, oddly enough, can enhance performance.

It’s also worth noting that the Army already employs gender‑neutral standards for many roles. Physical fitness tests, for instance, are the same for men and women. The military’s push toward equality isn’t about lowering standards; it’s about ensuring that anyone who meets those standards—whether cisgender or transgender—can serve.

Hegseth’s argument taps into a deeper cultural anxiety about the meaning of masculinity in the 21st‑century military. The image of a soldier as a stoic, testosterone‑driven warrior persists in movies, video games, and even recruitment ads. Yet the modern battlefield demands more than brute strength—it calls for technological savvy, emotional resilience, and teamwork.

When we reduce the discussion to “testosterone levels,” we risk missing the larger picture: the need for a force that can adapt to evolving threats, whether they’re cyber attacks or climate‑driven disasters. A soldier’s hormone profile is a tiny piece of a much larger puzzle that includes training, leadership, and esprit de corps.

That’s not to say the conversation isn’t worth having. The military does have a responsibility to ensure that any medical intervention—hormone therapy included—doesn’t jeopardize mission readiness. But the solution isn’t to retreat into nostalgic notions of “hard‑wired” masculinity. Instead, it’s to rely on evidence‑based policies, continuous health monitoring, and a culture that values every service member’s contribution.

In the end, Pete Hegseth’s commentary serves as a useful reminder that change can feel uncomfortable, especially in an institution as tradition‑laden as the armed forces. However, discomfort alone isn’t a sufficient reason to halt progress. If the goal is to keep America’s military the most effective fighting force on the planet, policymakers need to balance physiological concerns with the undeniable benefits of an inclusive, diverse roster of troops.

So the next time someone cites testosterone as the secret sauce of combat success, ask them to consider the full recipe: fitness, skill, cohesion, and—yes—a willingness to evolve with the times.